About the P. vivax information hub
Video on life-changing treatment to cure relapsing P. vivax malaria.
Vivax Working Group Annual meeting
15 -17th October Nepal
The Malaria in Pregnancy (MiP) Library now available on WWARN.
About 8.5 million people are at risk of malaria in Nepal. Despite this progress, there was a 20% increase from 2016 to 2017.
In this study, the prevalence and distribution of G6PD mutations were investigated across Ethiopia with the goal to provide additional information relevant to the use of primaquine in malaria treatment.
This tool assesses the cost-effectiveness of using G6PD RDTs prior to the administration of primaquine.
The vivax after falciparum Study Group was formed in March 2018, with an invitation to interested researchers with relevant data sets.
The biennial Reaching the Last Mile (RLM) Forum convenes global health leaders to share insights and best practices on how to map out, eliminate and eradicate infectious diseases.
Building bridges for solidarity and public health.
Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
This research reports a case of splenic infarction with acute kidney injury in a case of P. vivax malaria in a 13-year-old male child who presented to the emergency department with severe pain in the left hypochondrium.
This review argues that a healthy side-by-side maturation of both the parasite and its host cell, the reticulocyte, is necessary in the adaptation of P. vivax to in vitro growth and proposes that culture conditions and the media in play an essential role.
Malaria puts more than 3 billion people at risk of infection and causes high morbidity and mortality. Tafenoquine enables radical cure of malaria with a single dose and overcomes adherence issues associated with PQ,